Cogis Pharmaceuticals Inc is categorized under Commercial Biotechnical Research in Princeton Junction, NJ and active since 2008.
Cogis Pharmaceuticals Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Shahid Imran at the company’s single location by writing to 10 Hathaway Drive, Princeton Junction, New Jersey NJ 08550 or by phoning (609) 933-1213. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cogis Pharmaceuticals Inc |
| Contact Person: | Shahid Imran |
| Address: | 10 Hathaway Drive, Princeton Junction, New Jersey 08550 |
| Phone Number: | (609) 933-1213 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Cogis Pharmaceuticals Inc was started in 2008 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Shahid Imran for inquiries that concern Cogis Pharmaceuticals Inc by calling the company number (609) 933-1213, as your correspondence is most welcome. Additionally, the physical location of the single location of Cogis Pharmaceuticals Inc can be found at the coordinates 40.299708,-74.61346 as well as the street address 10 Hathaway Drive in Princeton Junction, New Jersey 08550.
For its online presence, you may visit Cogis Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.